Mutations in BRAF, NRAS, NF1, and KIT drive overactivation of the Ras/RAF/MAPK/ERK and PI3K/AKT/mTOR signaling pathways, promoting melanoma progression [14]. This evidence concerns the gene AKT1 and melanoma.